These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Esomeprazole: a safe alternative to lansoprazole allergy? Kara M; Tanoglu A; Kutlu A; Sirkeci O; Kekilli M Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):296-7. PubMed ID: 24659167 [TBL] [Abstract][Full Text] [Related]
4. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. Lobera T; Navarro B; Del Pozo MD; González I; Blasco A; Escudero R; Venturini M; Alarcón E J Investig Allergol Clin Immunol; 2009; 19(1):57-60. PubMed ID: 19274931 [TBL] [Abstract][Full Text] [Related]
5. Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity. Kepil Özdemir S; Yılmaz I; Aydin Ö; Büyüköztürk S; Gelincik A; Demirtürk M; Erdoğdu D; Cömert S; Erdoğan T; Karakaya G; Kalyoncu AF; Oner Erkekol F; Dursun AB; Misirligil Z; Bavbek S Allergy; 2013 Aug; 68(8):1008-14. PubMed ID: 23895584 [TBL] [Abstract][Full Text] [Related]
6. [Cross reactivity among proton pump inhibitors: does it exits?]. Garmendia Zallo M; Sánchez Azkarate A; Kraemer Mbula R; Liarte Ruano I; Nuñez Hernandez A; Cid De Rivera C Allergol Immunopathol (Madr); 2004; 32(2):92-5. PubMed ID: 15087098 [TBL] [Abstract][Full Text] [Related]
7. Immediate-Type Hypersensitivity Cross-Reactions to Proton Pump Inhibitors: A Descriptive Study of Data from the French National Pharmacovigilance Database. Tourillon C; Mahe J; Baron A; Lambert A; Yélehé-Okouma M; Veyrac G; Jolliet P Int Arch Allergy Immunol; 2019; 178(2):159-166. PubMed ID: 30485850 [TBL] [Abstract][Full Text] [Related]
8. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Clark DW; Strandell J Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264 [TBL] [Abstract][Full Text] [Related]
9. [Immediate type reactions to proton pump inhibitors using pantoprazole and omeprazole as examples]. Dohr J; Hunzelmann N; Brown A Hautarzt; 2018 Feb; 69(2):162-164. PubMed ID: 29085952 [TBL] [Abstract][Full Text] [Related]
10. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038 [TBL] [Abstract][Full Text] [Related]
11. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176 [TBL] [Abstract][Full Text] [Related]
12. Management of Hypersensitivity Reactions to Proton Pump Inhibitors: A Retrospective Experience. Kepil Özdemir S; Öner Erkekol F; Ünal D; Büyüköztürk S; Gelincik A; Dursun AB; Karakaya G; Bavbek S Int Arch Allergy Immunol; 2016; 171(1):54-60. PubMed ID: 27838693 [TBL] [Abstract][Full Text] [Related]
13. A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative. Turedi O; Sozener ZC; Kendirlinan R; Bavbek S Curr Drug Saf; 2017; 12(3):198-200. PubMed ID: 28699491 [TBL] [Abstract][Full Text] [Related]
14. A pharmacovigilance study of association between proton-pump inhibitors and rhabdomyolysis event based on FAERS database. Sun Y; Zhang A; Zuo M; Chen J; Zhu L J Gastroenterol Hepatol; 2024 Feb; 39(2):289-296. PubMed ID: 37961012 [TBL] [Abstract][Full Text] [Related]
15. Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions. Salgueiro E; Rubio T; Hidalgo A; Manso G Int J Clin Pharmacol Ther; 2006 Nov; 44(11):548-56. PubMed ID: 17176621 [TBL] [Abstract][Full Text] [Related]
17. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259 [TBL] [Abstract][Full Text] [Related]
18. Association Between Proton Pump Inhibitors and Microscopic Colitis. Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667 [TBL] [Abstract][Full Text] [Related]
19. Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro. Escoffier J; Arnaud B; Kaba M; Hograindleur JP; Le Blévec E; Martinez G; Stévant I; Ray PF; Arnoult C; Nef S Andrology; 2020 Nov; 8(6):1795-1804. PubMed ID: 32609951 [TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Gouraud A; Vochelle V; Descotes J; Vial T Clin Drug Investig; 2010; 30(8):559-63. PubMed ID: 20586518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]